Kolexia
Le Garff-Tavernier Magali
Pharmacien
Hôpital Pitie Salpetriere
Paris, France
141 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Leucémies Leucémie chronique lymphocytaire à cellules B Leucémie lymphoïde Tumeurs du système nerveux central Maladie résiduelle Lymphome intraoculaire Récidive tumorale locale Macroglobulinémie de Waldenström

Industries

Janssen
12 collaboration(s)
Dernière en 2023
Alexion
8 collaboration(s)
Dernière en 2021
Novartis
4 collaboration(s)
Dernière en 2023
Abbvie
3 collaboration(s)
Dernière en 2022

Dernières activités

Analysis of cerebrospinal fluid for the diagnosis of CNS lymphoma: Comparison of the ESCCA/ISCCA protocol and real-world data of the CytHem/LOC French network.
Cytometry. Part B, Clinical cytometry   07 mars 2024
Circulating tumor cells in Waldenström macroglobulinemia.
Leukemia   09 février 2024
Progressive multifocal leukoencephalopathy in patients with chronic liver disease successfully treated with pembrolizumab.
Journal of neurology   24 décembre 2023
Highly Sensitive Interleukin Score for Intra-Ocular Lymphoma Diagnosis: Evidence from Analysis of 5-Year Real-Life of Use
65th ASH Annual Meeting Abstracts   02 novembre 2023
Combination Chemotherapy in Patients with Newly Diagnosed Blastic Plasmacytoid Dendritic Cell Neoplasms (BPDCN): First Results of a Prospective French Trial (LpDessai)
65th ASH Annual Meeting Abstracts   02 novembre 2023
Neutrophil PNH Type II Cells Are Associated with Thrombosis and Bone Marrow Failure without Hemolysis: Evidence from Analysis of the 5-Year French Nation-Wide Multicenter Observational Study
65th ASH Annual Meeting Abstracts   02 novembre 2023
Halting progressive multifocal leukoencephalopathy with pembrolizumab: the case of a patient with multiple sclerosis under fingolimod.
Journal of neurology   01 novembre 2023
P14.08.A PROGNOSTIC VALUE OF CSF IL-10 AT THE 2-MONTH ASSESSMENT AFTER THE START OF INDUCTION CHEMOTHERAPY IN PRIMARY CNS LYMPHOMAS. A LOC NETWORK STUDY
Abstracts from the 18th Meeting of the European Association of Neuro-Oncology   08 septembre 2023
JS03.6.A NEUROTOXICITY IN PATIENTS WITH CNS LYMPHOMAS TREATED WITH CAR T CELL THERAPY. A LOC NETWORK STUDY
Abstracts from the 18th Meeting of the European Association of Neuro-Oncology   08 septembre 2023
A fixed-duration immunochemotherapy approach in CLL: 5.5-year results from the phase 2 ICLL-07 FILO trial.
Blood advances   28 juillet 2023